Innovative Trials acquires first US office as part of mission to support patient access to clinical trials

Innovative Trials, a global clinical trial patient recruitment, retention and engagement company, has opened its first international office in the US, signaling its commitment to accelerating patient access to life-changing treatments within North America.

The new office is based in Raleigh, North Carolina, within the state’s Research Triangle - one of the most prominent areas in the country for pharmaceutical research and development (R&D).

The move by Innovative Trials is in response to growing business demand from global pharmaceutical companies and Clinical Research Organizations (CROs), and Innovative Trials’ own business growth strategy developed by CEO, Kate Shaw. The company also hopes to expand its operations through a US recruitment drive later this year.

Kate Shaw, Founder and CEO of Innovative Trials, said: “Our expansion into the US, marked by the opening of our new office, is a significant step forward towards our goal of enabling patients to access new treatment options more quickly through clinical trials.

“The US is one of the fastest growing clinical trial markets, so having a local presence is crucial to our future as a company. With North Carolina widely regarded as the epicenter of pharma R&D within the US, this move will enable us to bring our services closer to existing and potential clients while also allowing us to expand our commitment to the US market by growing our team.”

Innovative Trials, which was named Best Global Patient Recruitment Company of 2021, supports clinical trial sites and sponsors to meet patient recruitment targets and deadlines, and avoid costly delays in bringing effective new treatments to market. The company has so far supported around 300 clinical trials globally across 25 separate therapy areas and played a part in six new treatments being approved for patients across the world.

The company employs more than 60 members of staff at its UK head office with a further 65 people stationed overseas. However, the US office is the second permanent base for the business and has been strategically selected to enable business growth.

In the US, Innovative Trials currently has 14 employees: five full-time members of staff and nine part-time Clinical Enrollment Managers (CEMs) who are situated across the country. More hires are expected in the coming months to support and grow its US operations.

Whitney Taynton, Innovative Trials’ Business Unit Head based in North Carolina, said: “Our new office will enable us to provide greater operational and strategic flexibility to ensure our bespoke patient engagement and recruitment solutions fit clients’ needs, and grow our workforce to support even more sites and sponsors. I can’t wait to welcome more colleagues on board and contribute to making Innovative Trials a real force to be reckoned with here in the US.”

Kari Reilly, Patient Recruitment Manager for Innovative Trials in the US, added: “I am excited for the future of Innovative Trials here in the US. The establishment of our North Carolina office is a bold step that highlights just how committed the company is to supporting patient access to clinical trials in this country and investing in its staff.” 

Innovative Trials will continue to be managed by CEO, Kate Shaw, from its Hertfordshire base in the UK. For more information about the company, visit www.innovativetrials.com